AngioDynamics, Inc. (ANGO) — Analysis Summary
AngioDynamics, Inc. (ANGO) has a market cap of $641.07M with year-over-year revenue growth of +9.5%. Net margin stands at -11.5%. The stock trades at a P/E ratio of -17.4.
Key Takeaways
- Revenue changed +9.5% year-over-year
- Net margin of -11.5%
- P/E ratio of -17.4
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, ANGO posted revenue growth of +9.5% and trades at a P/E of -17.4.
AngioDynamics, Inc. (ANGO)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Operating margin at -12.5% — material operating losses
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
632
Headquarters
LATHAM, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.